Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia.
Zhao X, Wang P, Diedrich JD, Smart B, Reyes N, Yoshimura S, Zhang J, Yang W, Barnett K, Xu B, Li Z, Huang X, Yu J, Crews K, Yeoh AEJ, Konopleva M, Wei CL, Pui CH, Savic D, Yang JJ.
Zhao X, et al. Among authors: crews k.
Nat Commun. 2022 Sep 14;13(1):5401. doi: 10.1038/s41467-022-33143-w.
Nat Commun. 2022.
PMID: 36104354
Free PMC article.